Reckitt is reaping the rewards of R&D investments in its Health business, according to CEO Kris Licht.
Reckitt Sees R&D Investment Translate To Volume Growth
R&D investments behind consumer health brands such as Nurofen and Durex pay off for Reckitt in Q1 as it sees volume growth across majority of portfolio.
